Use of stable isotopes in the study of pharmacokinetics of drugs by mass fragmentography II: Detailed examination of pharmacokinetics of a single oral dose of phenytoin in humans

This publication has 36 references indexed in Scilit:

• Determination of Phenytoin in Plasma: A Comparison of Procedures Using a New Radioimmunoassay, Gas Chromatography, and Enzyme Immunoassay
  Epilepsia, 1978
• Studies on drug metabolism by use of isotopes. 23. Metabolic study of 1-butyryl-4-cinnamylpiperazine in the rat during development of tolerance by using two kinds of deuterium-labeled forms
  Journal of Medicinal Chemistry, 1978
• Therapeutic Drug Monitoring in Saliva
  Clinical Pharmacokinetics, 1978
• Studies on drug metabolism by use of isotopes. XVII. Mass spectrometric quantification of urinary metabolites of deuterated l-ephedrine in man.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
• Mass fragmentographic determination of unlabeled and deuterium labeled methadone in human plasma. Possibilities for measurement of steady state pharmacokinetics
  Journal of Mass Spectrometry, 1975
• Importance of the use of the appropriate pharmacokinetic model to analyzein vivo enzyme constants
  Journal of Pharmacokinetics and Biopharmaceutics, 1974
• Pharmacokinetics of single and multiple doses of phenytoin in man
  European Journal of Clinical Pharmacology, 1974
• A new metabolite of 5,5-diphenylhydantoin (Dilantin++Dilantin is the Parke-Davis trade name for 5,5-diphenylhydatoin (phenytoin).)
  Biochemical and Biophysical Research Communications, 1970
• Kinetics of Diphenylhydantoin Disposition in Man
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1970
• Researches on Substituted 5-Phenylhydantoins¹
  Journal of the American Chemical Society, 1954